Area of research
Immunology · Molecular Biology
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer Research and Treatments, Acute Myeloid Leukemia Research, and interferon and immune responses.
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer
Ubiquitinome Profiling Reveals in Vivo UBE2D3 Targets and Implicates UBE2D3 in Protein Quality Control
Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin
Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cells
Maintenance of epithelial traits and resistance to mesenchymal reprogramming promote proliferation in metastatic breast cancer
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Inactivation of Citron Kinase Inhibits Medulloblastoma Progression by Inducing Apoptosis and Cell Senescence
Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Absence of NKG2D Ligands Defines Human Acute Myeloid Leukaemia Stem Cells and Mediates Their Immune Evasion
Characteristic Amino Acid and Energy Metabolism in AML Stem Cells As Revealed By Quantitative Multiplex Proteomics
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma